Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility) is Buildings and Property in United States that focus on certain assets business. They cover business area such as portfolio, manufacturing right, facility, stimuvax therapeutic vaccine, current inventory, certain asset, non-small-cell lung cancer.
-
Certain Assets
-
2601 Fourth Avenue
Suite 500
Seattle, WA 98121
United States
Private
portfoliomanufacturing rightfacilitystimuvax therapeutic vaccinecurrent inventorycertain assetnon-small-cell lung cancer
* We use standard office opening hours in near Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cascadian Therapeutics (Stimuvax Manufacturing Rights And Facility) is Buildings and Property business from United States that founded in - ( years old in ), Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility) business is focusing on Certain Assets.
Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility) headquarter office and corporate office address is located in 2601 Fourth Avenue Suite 500 Seattle, WA 98121 United States.
Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility) was founded in United States.
In , Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility) is currently focus on certain assets sector.
Above is snippet of Google Trends for "certain assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cascadian Therapeutics (Stimuvax Manufacturing Rights and Facility), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
